CGEM

CGEM EBITDA Margin

-356.22%TTM

Period ending:

CGEM FY EBITDA Margin%
CGEM FY EBITDA Margin42.72%-398.69%
2018-12-312025-12-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods. Dates are period ends; a fiscal year may differ from a calendar year.

CGEM ebitda margin history

EBITDA as a percentage of revenue. The available annual fiscal periods series contains 8 observations from Dec 31, 2018 to Dec 31, 2025.

Cullinan Therapeutics Inc EBITDA Margin — Annual fiscal periods
Period endingEBITDA Margin
0%
0%
0%
0%
-355.9732%
0%
0%
0%

Compare ebitda margin

All CGEM financial metrics · CGEM stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.